Atlas Trials

A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers

Clinical trial NCT02634073 · COMPLETED

Trial details

NCT number
NCT02634073
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2016-01-01
Primary completion
2016-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.